ARROWMARK PARTNERS
ArrowMark Partners is an SEC-registered investment adviser based in Denver, Colorado. Their investment objective is clear: deliver consistent, asymmetric, non-correlated, risk-adjusted returns by applying fundamental research across the capital structure. They focus on compounding wealth by delivering unique, client-driven and absolute return solutions.
ARROWMARK PARTNERS
Social Links:
Industry:
Financial Services
Founded:
2007-01-01
Status:
Active
Contact:
303.398.2929
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Nginx
Similar Organizations
Lone Pine Capital
Lone Pine Capital is an investment adviser that invests in equities and equity-related securities.
Morgan Creek Capital Management
Morgan Creek Capital Management is an investment adviser providing investment management services to institutions and wealthy families.
Oaktree Capital Management
Oaktree Capital Management is a privately owned investment manager specializing in alternative investment strategies.
Rx3 Growth Partners
Rx3 Growth Partners is a consumer focused investment fund based in Orange County.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | Aktis Oncology | ArrowMark Partners investment in Series A - Aktis Oncology | 84 M USD |
| 2022-06-14 | Dren Bio | ArrowMark Partners investment in Series B - Dren Bio | 65 M USD |
| 2022-02-17 | Beta Bionics | ArrowMark Partners investment in Series C - Beta Bionics | 57 M USD |
| 2022-01-27 | Simcha Therapeutics | ArrowMark Partners investment in Series B - Simcha Therapeutics | 40 M USD |
| 2022-01-19 | Big Health | ArrowMark Partners investment in Series C - Big Health | 75 M USD |
| 2021-12-07 | Freenome | ArrowMark Partners investment in Series D - Freenome | 300 M USD |
| 2021-11-09 | Arbor Biotechnologies | ArrowMark Partners investment in Series B - Arbor Biotechnologies | 215 M USD |
| 2021-11-08 | Fyllo | ArrowMark Partners investment in Series C - Fyllo | 40 M USD |
| 2021-10-27 | Skyryse | ArrowMark Partners investment in Series B - Skyryse | 200 M USD |
| 2021-10-26 | DNA Script | ArrowMark Partners investment in Series C - DNA Script | 165 M USD |
Newest Events participated